Search Results
Results found for "Design Pharmaceuticals"
- GPCR Buzz of the Week | Sep 23 - 29, 2024
November 14th : The Application of GPCR Ligand Kinetics to Candidate Design. potential agonists of orphan receptor GPR78 targeting CNS disorders Predicting biological activity and design
- Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
role, she will focus on the application of artificial intelligence (AI), machine learning, and the design
- Structural basis for receptor selectivity and inverse agonism in S1P5 receptors
, which clarifies the receptor subtype selectivity and provides a template for structure-based drug design
- 📰 GPCR Weekly News, November 20 to 26, 2023
Insights into GPCR Function Structural and signaling mechanisms of TAAR1 enabled preferential agonist design Showcases Innovative AI-Driven Drug Design at BRIC AI 2023 Workshop Salipro Biotech AB Celebrates Milestones
- Mechanistic Understanding of the Palmitoylation of Go Protein in the Allosteric Regulation of...
aGPCRs via post-translational modifications of the Go protein, and offers guidance for future drug design
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
This talk gave a general idea of what goes into designing small molecule drugs, using state-of-the-art
- Lysine 101 in the CRAC Motif in Transmembrane Helix 2 Confers Cholesterol-Induced Thermal...
that our results could have potential implications in structural biological advancements of GPCRs and design
- Pharmacological Properties and Function of PxOctβ3 Octopamine Receptor in Plutella xylostella (L.)
pharmacological properties and functions of PxOctβ3 in P. xylostella, thus, providing a theoretical basis for the design
- Accelerating GPCR Drug Discovery
Systems That Drive Progress: From assay tracking to data workflows, I design simple, scalable tools
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
the Next Stage of its Evolution "New team focused on expanding its GPCR-focused structure-based drug design
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
who has just released an incredible article on our site and a GPCR Paper with his team: Targeted Drug Design November 14th : The Application of GPCR Ligand Kinetics to Candidate Design.
- Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024
Our updated course schedule is designed to fit seamlessly into your routine, offering an enriched learning Boston, MA 📅 October 2 -3, 2024 Join top researchers to explore the latest in GPCR-targeted drug design
- Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop ...
Group Corporation (“the Company”; TSE: 4565), the world leader in GPCR-focused structure-based drug design
- Functional molecular switches of mammalian G protein-coupled bitter-taste receptors
We designed an integrative approach to improve comparative modeling of TAS2Rs.
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
co-internalization Kilian Roßmann , Ramona Birke , Joshua Levitz , Ben Jones , Johannes Broichhagen Design extracellular loops on a soluble scaffold enabled the discovery of antibodies, which recognized native receptor Design
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
brain vs. peripheral contributions to metabolic therapy Guide how next-generation incretin drugs are designed
- From GPCR Data Chaos to Decisive Action
Here’s what I bring: Biology-First Strategy I’ve designed GPCR assays, led collaborations across research
- Using Live-cell High-Content Screening to Characterize CB2 Ligands: Insights From 16 Synthetic Cannabinoids
understandings of CB2 signaling, tools that preserve cellular context will be increasingly important for designing Three-dimensional quantitative structure–selectivity relationships analysis guided rational design of
- 📰 GPCR Weekly News, February 19 to 25, 2024
restoration of tension in epithelial cells GPCR Binders, Drugs, and more Advances in structure-based drug design copolymers and SMALPs as a platform for investigating GPCRs Reviews, GPCRs, and more Fragment-Based Design
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
Nasdaq debutante Septerna swells its IPO to $331m Nxera Pharma and Antiverse Enter Collaboration To Design Using Generative AI Zombie Fungi Hijack Hosts’ Brains GPCR Therapeutics, Inc. has received Orphan Drug Designation
- Roles of Focal Adhesion Kinase PTK2 and Integrin αIIbβ3 Signaling in Collagen- and GPVI-Dependent...
We designed and synthetized peptides that interfered with integrin αIIb binding (pCIB and pCIBm) or mimicked
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Our refreshed schedule is designed to fit seamlessly into your calendar and enhance your learning experience (October 2-3, 2024, in Boston and online) gathers top researchers to explore the latest advances in designing
- Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...
The pharmacological profiles and mechanistic insights of our study provide clues for the future design
- Targeting Intracellular Allosteric Sites in GPCRs
The process of designing and evaluating biased ligands for GPCRs is complex but essential for understanding Advances in understanding the structural and mechanistic aspects of biased GPCR signaling are crucial for designing
- A new Kunitz-type snake toxin family associated with an original mode of interaction with the...
MQ1-K39A represents the first step in the improvement of the MQ1 design from a medicinal perspective.
- Why Fundraising Mistakes Kill Strong Biotech Startups
👉 When that question becomes dominant, strategy quietly shifts from intentional design to reactive justification Founders delay narrowing focus, hoping clarity will emerge after the round instead of designing it upfront
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
to PK–PD dissociation, Kenakin equips you with the kinetic models and biological context needed to design
- How Fast Does a Drug Work?
Kenakin’s latest lecture delivers exclusive, real-world insight designed to equip you to move beyond
- Enhancing GPCR Research Outreach | Dr GPCR University early-bird registration ends soon!
Logo Contest : Let your creativity shine by submitting your design for the Logo Contest before August
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
At Celtarys, our GPCR fluorescent ligands are designed with a variety of photophysical properties to
















